Business Context and Reporting Period
This Form 8-K is a current report filed by Concentra Group Holdings Parent, Inc. on July 6, 2026. The filing discloses a consulting agreement entered into with Dr. John R. Anderson, who is retiring from his position as Executive Vice President and Chief Medical Officer effective December 31, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and employment arrangements rather than financial performance.
Material Changes
The primary material change disclosed is the transition of Dr. John R. Anderson from an executive officer to an independent contractor. Key terms of the new arrangement include:
- Effective Date: January 1, 2027.
- Term: Through December 31, 2027.
- Scope: Up to 10 hours per week focusing on clinical strategy, medical affairs, and regulatory matters.
- Compensation: $216.00 per hour.
- Equity Vesting: Outstanding unvested restricted stock awards will continue to vest if services are provided. An additional 25% of then-unvested restricted stock will automatically vest upon completion of the full term without termination for Cause or voluntary resignation.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary contingency noted is the forfeiture of all unvested equity awards if Dr. Anderson is terminated for Cause or voluntarily resigns prior to the expiration of the consulting term. Equity benefits are also subject to the execution of general and final releases of claims.
Key Facts for Investor Verification
- Verify the total potential equity payout for Dr. Anderson based on the number of unvested shares and the 25% acceleration clause.
- Confirm the specific definition of "Cause" referenced from the 2010 Employment Agreement to understand termination risks.
- Review the full text of the Consulting Agreement (Exhibit 10.1) for non-compete or non-solicitation clauses not detailed in the summary.
- Monitor the company's succession plan for the Chief Medical Officer role following the December 31, 2026, retirement date.